To the technically curious: Retatrutide is really a artificial peptide created for at the time-weekly dosing, using a 50 %-lifetime of roughly 6 times. It's designed on a GIP peptide backbone and it is most powerful at the GIP receptor, moderately powerful at GLP-one, and mildest on the glucagon receptor.This follows Novo Nordisk's playbook (Ozempi